MANKIND.NS Earnings — Mankind Pharma Limited

NSE

Updated Oct 30, 2026

Price —

Market Cap $1.0T

P/E 46.6

52W Range — – —

When is MANKIND.NS's next earnings date?

Mankind Pharma Limited (MANKIND.NS) has not announced its next earnings date yet. Its most recent earnings report was on Monday, October 26, 2026.

How did MANKIND.NS do in its last earnings report?

In its most recent report on Oct 26, 2026, Mankind Pharma Limited posted EPS of $17.20 versus the $15.22 estimate, a beat. Revenue was $43.01B against a $41.63B estimate.

How much does MANKIND.NS stock move after earnings?

MANKIND.NS beat EPS estimates in 2 of its last 2 reported quarters.

About Mankind Pharma Limited

Mankind Pharma Limited specializes in the development, manufacturing, and marketing of a broad range of pharmaceutical medications and consumer health goods. Operating predominantly in India, the company also caters to international markets. Its pharmaceutical division focuses on both acute and chronic therapeutic areas, encompassing a wide spectrum of medical conditions such as infectious diseases, cardiovascular ailments, gastrointestinal disorders, diabetes, dermatology, pain management, neuro/CNS issues, nutritional support (vitamins/minerals), and respiratory problems. Complementing its pharmaceutical portfolio, the consumer healthcare segment offers diverse products, including condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations. Key brands under its umbrella include Manforce, Prega News, Unwanted-72, Gas-O-Fas, Health OK, and AcneStar. Furthermore, the company's business activities are diversified, extending to the trading and export of pharmaceutical and healthcare products, as well as the manufacturing of various goods such as packaging materials, ayurvedic products, bulk drugs, and general consumer items. Mankind Pharma also holds interests in real estate, leasing, hospitality, and IT services. Established in 1986, Mankind Pharma Limited maintains its headquarters in New Delhi, India.